View all newsletters
Receive our newsletter – data, insights and analysis delivered to you
  1. News
June 1, 2018

Schrödinger and Canada’s CDRD partner to develop cancer biologics

US-based drug discovery technology provider Schrödinger has partnered with Canada’s Centre for Drug Research and Development (CDRD) to create new cancer biologics, including immuno-oncology monoclonal antibodies.

US-based drug discovery technology provider Schrödinger has partnered with Canada’s Centre for Drug Research and Development (CDRD) to create new cancer biologics, including immuno-oncology monoclonal antibodies.

The CDRC will supply targeted antibodies, which will be analysed by Schrödinger using its computation platform to prioritise the drug candidates and, if needed, enhance discovery.

Initially, the companies plan to work on an immune checkpoint target found on cancer stem cells.

Schrödinger president and CEO Ramy Farid said: “We’re excited to work with CDRD to aggressively translate scientific discoveries into innovative therapeutic products.

“This partnership is an important step forward in our efforts to extend the successes we’ve had in small molecule drug discovery.”

“This partnership is an important step forward in our efforts to extend the successes we’ve had in small molecule drug discovery to the development of novel biologics.”

As per the agreement, Schrödinger will predict physico-chemical liabilities and antibody humanisation in order to support hit triage and prioritisation, while CDRD will deliver critical molecular and physicochemical measurements for the antibody portfolio.

CDRD president and CEO Gordon McCauley said: “Schrödinger is the leader in applying in silico modelling to small molecule drug discovery, and we are excited to be a part of this unique collaboration leveraging those capabilities to speed biologics discovery.

“This collaboration also highlights our partnership with BCCA and our collaborative approaches as we work to advance groundbreaking cancer research from bench to bedside.”

Related Companies

NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. A weekly roundup of the latest news and analysis, sent every Friday. The pharmaceutical industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy
SUBSCRIBED

THANK YOU